Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: 4AP for Carpal Tunnel Syndrome (CTS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 4-aminopyridine (4-AP) for Carpal Tunnel Syndrome is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 4-aminopyridine (4-aminopyridine)

Snippet

Sponsor: John Elfar | Conditions: Compression Neuropathy, Carpal Tunnel Syndrome | Phase 2 | Status: NOT_YET_RECRUITING